Content by Keyword: Mental Health and Substance Abuse

  • print
  • email
  • twitter
  • compact
Report page
EXECUTIVE SUMMARY

Examining Substance Use Disorder Treatment Demand and Provider Capacity in a Changing Health Care System: Final Report. EXECUTIVE SUMMARY

Despite federal policies enacted within the last decade aimed at promoting insurance coverage for substance use disorders (SUDs), the existing SUD treatment workforce may be insufficient to accommodate the potential increase in demand for care and other factors may be contributing to stagnant treatment utilization rates. To address this concern, i
Report page
ACRONYMS

Examining Substance Use Disorder Treatment Demand and Provider Capacity in a Changing Health Care System: Final Report. ACRONYMS

The following acronyms are mentioned in this report and/or appendices.
Report
Examining Substance Use Disorder Treatment Demand

Examining Substance Use Disorder Treatment Demand and Provider Capacity in a Changing Health Care System: Final Report

Ellen Bouchery Mathematica Policy Research December 5, 2017 Printer Friendly Version in PDF Format (101 PDF pages) ABSTRACT
PDF report
Examining Substance Use Disorder Treatment Demand

Examining Substance Use Disorder Treatment Demand and Provider Capacity in a Changing Health Care System: Final Report

Federal policies implemented in the last decade, including the Affordable Care Act (ACA) and the Mental Health Parity and Addiction Equity Act, have promoted insurance coverage for substance use disorders (SUDs). By providing funding for treatment services, these federal policies were intended to increase the proportion of individuals with SUDs wh
  • ExamSUDfr.pdf
    export-csvPDF
Basic report
Substance Use Disorder Workforce Issue Brief

Substance Use Disorder Workforce Issue Brief

Ellen Bouchery, Mathematica Policy Research Judith Dey, U.S. Department of Health and Human Services Printer Friendly Version in PDF Format (5 PDF pages)
PDF report
Substance Use Disorder Workforce Issue Brief

Substance Use Disorder Workforce Issue Brief

Many barriers to accessing evidence-based treatment for substance use disorder (SUD), particularly medication assisted treatment, are related to the workforce. Barriers include workforce shortages for certain providers, insufficient training, education and experience, lack of institutional and clinician peer support, provider stigma and inadequate
  • ExamSUDib.pdf
    export-csvPDF
Basic report
The Use of 1915(i) Medicaid Plan Option for

The Use of 1915(i) Medicaid Plan Option for Individuals with Mental Health and Substance Use Disorders

Stan Dorn, Rebecca Peters and Morgan Cheeks Urban Institute Pat Casanova and Gina Eckart Health Management Associates Ted Lutterman National Association of State Mental Health Program Directors Research Institute, Inc. Printer Friendly Version in PDF Format (37 PDF pages)
PDF report
The Use of 1915(i) Medicaid Plan Option for

The Use of 1915(i) Medicaid Plan Option for Individuals with Mental Health and Substance Use Disorders

Created by the Deficit Reduction Act of 2005 and amended by the Patient Protection and Affordable Care Act (ACA), Section 1915(i) of the Social Security Act gives state Medicaid programs the flexibility to cover home and community-based services (HCBS) through a Medicaid state plan amendment (SPA) without the need to seek a federal waiver. This re
  • 1915iSPA.pdf
    export-csvPDF
PDF report
Adolescent Well-Being after Experiencing Family

Adolescent Well-Being after Experiencing Family Homelessness

New analysis of data from HUD's Family Options Study of adolescents’ experiences in shelter with their families and 20 months later shows that most adolescents continued to live with their families, and some continued to experience housing instability or live in overcrowded situations. These adolescents were more likely to have changed schools o
  • adolescents.pdf
    export-csvPDF
Report page
PROJECT INFORMATION AND ADDITIONAL REPORTS

Review of Medication-Assisted Treatment Guidelines and Measures for Opioid and Alcohol Use. Project Information and Additional Reports

DEVELOPMENT AND TESTING OF BEHAVIORAL HEALTH QUALITY MEASURES
Report page
REFERENCES

Review of Medication-Assisted Treatment Guidelines and Measures for Opioid and Alcohol Use. References

American Society of Addiction Medicine (ASAM). "Opioid Addiction Disease 2015 Facts and Figures." Available at http://www.asam.org/docs/default-source/advocacy/opioid-addiction-disease-facts-figures.pdf .
Report page
F. SUMMARY

Review of Medication-Assisted Treatment Guidelines and Measures for Opioid and Alcohol Use. F. Summary

The guidelines provide recommendations on the use of MAT across treatment phases with an emphasis on the maintenance phase. Most of the guidelines were developed based upon expert opinion and scientific literature. Some guidelines focus on special populations and over half mention psychosocial treatment. The strength of the recommendation varies f
Report page
E. SUMMARY OF MEDICATION-ASSISTED TREATMENT

Review of Medication-Assisted Treatment Guidelines and Measures for Opioid and Alcohol Use. E. Summary of Medication-assisted Treatment Quality Measures

TABLE 3 . MAT for Opioid Use Measures Measure Denominator Numerator
Report page
D. VARIATION IN KEY FEATURES OF MEDICATION-

Review of Medication-Assisted Treatment Guidelines and Measures for Opioid and Alcohol Use. D. Variation in Key Features of Medication-assisted Treatment Clinical Guidelines

Stages of Treatment . Both opioid and alcohol use MAT guidelines tend to focus on stages of treatment -- assessment, withdrawal management (also referred to as detoxification), and maintenance -- whereby the recommended dosage of medication and frequency and intensity of MAT vary with the stage of treatment and the client's needs.
Report page
C. SUMMARY OF MEDICATION-ASSISTED TREATMENT

Review of Medication-Assisted Treatment Guidelines and Measures for Opioid and Alcohol Use. C. Summary of Medication-assisted Treatment

TABLE 1 . Summary of MAT Guidelines for Opioid Use Guideline Name (publication year) (appendix table #) Setting Stage(s) of
Report page
B. APPROACH TO REVIEW

Review of Medication-Assisted Treatment Guidelines and Measures for Opioid and Alcohol Use. B. Approach to Review

Even though the roadmap focuses on MAT for opioid use, we recognize that clinical guidelines and measures related to MAT for alcohol and other SUDs could be useful to guide the approach to developing and implementing MAT measures for opioid use. As such, we searched for and reviewed clinical guidelines that include MAT for opioid and alcohol use p
Report page
A. INTRODUCTION

Review of Medication-Assisted Treatment Guidelines and Measures for Opioid and Alcohol Use. A. Introduction

Opioid overdoses claim 17,000 American lives annually (ASAM 2015). Deaths by opioid overdose have nearly quadrupled from 1999 to 2013 (CDC 2015). Nearly 2.5 million Americans are currently at risk for overdoses -- 1.9 million are opioid-dependent, and 517,000 are addicted to heroin (ASAM 2015). In response to the growing opioid epidemic, the U.S.
Report page
ACRONYMS

Review of Medication-Assisted Treatment Guidelines and Measures for Opioid and Alcohol Use. Acronyms

The following acronyms are mentioned in this report and/or appendices.
Report page
APPENDIX C. ALCOHOL USE: MEDICATION-ASSISTED

Review of Medication-Assisted Treatment Guidelines and Measures for Opioid and Alcohol Use. Appendix C. Alcohol Use: Medication-assisted Treatment and Other Related Measures

TABLE C.1 . Alcohol Use: MAT and Other Related Measures Measure Denominator Numerator
Report page
APPENDIX B. MEDICATION-ASSISTED TREATMENT FOR

Review of Medication-Assisted Treatment Guidelines and Measures for Opioid and Alcohol Use. Appendix B. Medication-assisted Treatment for Alcohol Use Clinical Guidelines: Verbatium Excerpts From Relevant Guideline Sections

LIST OF TABLES TABLE B.1 : SAMHSA and NIAAA: Brief Guide to Medication for the Treatment of Alcohol Use Disorder TABLE B.2 : NICE: Technology Appraisal Guidance of Nalmefene for Reducing Alcohol Consumption in People with Alcohol Dependence TABLE B.3 : WHO: Guidelines for the Identification and Management of Substance Use and SUD in Preg

Pages

Form Approved OMB# 0990-0379 Exp. Date 9/30/2020